Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Am J Transplant. 2017 Nov 1;18(4):843–854. doi: 10.1111/ajt.14523

Figure 6. Syngeneic rat DCD renal transplant model, CD47mAb treatment reduced oxidative stress.

Figure 6

(A) IF staining of PARP and VDAC1 (magnification ×200) showed lower in the CD47mAb-treated group. (B) Western blot and densitometry analysis showed that expression of activated PARP and VDAC1 were markedly lower in CD47mAb treated group compared to IgG control group.